Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-03-01
1984-12-25
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
424 85, 424 87, 436548, A61K 39395, A61K 3942, G01N 3354, G01N 3356
Patent
active
044903588
ABSTRACT:
Mammals are vaccinated against infectious organisms and polypeptides are screened for utility as vaccines by a complementing set of monoclonal antibodies, the first of which antibodies binds specifically to the site on the organism which itself binds specifically to a receptor on a host cell of the mammal, and the second of which binds specifically to the first. Vaccination is done with the second antibody alone, and screening is done by determining whether the polypeptide binds to the first antibody.
REFERENCES:
Nisonoff et al., Clinical Immunology and Immunopathology, vol. 21, pp. 397-406 (1981).
Moshly-Rosen et al., FEBS Letters, vol. 106, 389-392 (1979).
Letvin et al., The J. of Immunology, vol. 127, 2334-2339 (1981).
Nepom et al., J. Exp. Med., vol. 155, 155-167 (1982).
Fields Bernard N.
Greene Mark I.
Hazel Blondel
President and Fellows of Harvard College
LandOfFree
Screening vaccines and immunization process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening vaccines and immunization process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening vaccines and immunization process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1152378